Navigation Links
Obesity Organizations Call for a Full and Fair Hearing When the FDA Reviews New Treatments for Obesity
Date:12/6/2010

SILVER SPRING, Md., Dec. 6, 2010 /PRNewswire-USNewswire/ -- The Obesity Society (TOS) and the Obesity Action Coalition (OAC) today called on the Food and Drug Administration (FDA) to consider the urgent need for more tools to address the obesity epidemic facing more than 93 million Americans as they convene an advisory panel to review a new treatment for obesity.

On December 7, the FDA Endocrine and Metabolic Advisory will review a New Drug Application for Contrave, for the treatment of obesity.  In October, the FDA rejected two other newly developed obesity treatments, Qnexa (phentermine/topirimate) and Lorquess (lorcaserin), citing safety concerns. Also in October, the FDA asked for the removal of the previously approved weight-loss drug Meridia (sibutramine) from the market due to safety concerns.  

Jennifer Lovejoy, PhD, President of TOS commented, "We are deeply concerned about the effect that the FDA's recent decisions will have for on-going and future research into desperately needed new obesity treatments. As the FDA's advisors consider the application before them, we hope that the agency will assure a balanced process, taking into account the urgent medical need."

A study published in the most recent New England Journal of Medicine provides a stark reminder that the obesity epidemic is a deadly disease.  In a study of mortality in 1.46 million people sponsored by the NIH, investigators reported that weight classifications "overweight" and "obesity" are associated with significant excess mortality.

"The time for action is now," said Joe Nadglowski, OAC President and CEO. "The number of those affected by obesity is growing at an incredibly rapid rate and the millions of Americans already affected by the disease are lacking the necessary medically approved treatment and long-term options so desperately needed."

Both TOS and the OAC greatly hope that the FDA and its advisors can play a proactive and constructive role to improve this extremely serious situation. "It is imperative that the FDA review any obesity treatment presented to them with the understanding that more than 93 million Americans are depending on them for help with this disease," said Lovejoy.

About The Obesity Society

The Obesity Society (www.obesity.org) is the leading scientific organization in North America dedicated to the study of obesity. The Obesity Society is committed to encouraging research on the causes and treatment of obesity and keeping the medical community and public informed of new advances. The Obesity Society's vision is to be the leader in understanding, preventing and treating obesity and in improving the lives of those affected. The Obesity Society's membership comprises approximately 2500 basic and clinical researchers, who have published extensively, and care providers in obesity treatment and prevention.

About the OAC

The mission of the Obesity Action Coalition (www.obesityaction.org) is to elevate and empower those affected by obesity through education, advocacy and support.


'/>"/>
SOURCE The Obesity Society
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
2. InfraReDx to Present at Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference
3. HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference
4. Obesity and Diabetes Are Increasing in Cats
5. American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America
6. Results of Two New Clinical Studies Show Promise of Emerging Mobile Health Technology to Combat Obesity Epidemic
7. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
8. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
9. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
10. SIRIUS XMs Doctor Radios The Deans List To Focus On Link Between Early Antibiotic Use In Children And Obesity
11. FierceBiotech Names Obesity Company Gelesis to Fierce 15 List of Top Emerging Biotech Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):